What is CardiOptics?
CardiOptics specializes in providing comprehensive and accessible screening services for heart, vascular, and cancer conditions. Leveraging advanced ultrasound technology, the company delivers efficient, cost-effective, and confidential health assessments administered by board-certified specialists directly at client facilities. Primarily targeting corporate environments, CardiOptics aims to proactively identify potential health issues among employees, thereby mitigating long-term medical costs and reducing productivity losses. Their commitment to non-invasive and rapid screenings is central to improving overall workplace health outcomes.
How much funding has CardiOptics raised?
CardiOptics has raised a total of $60K across 1 funding round:
Debt
$60K
Debt (2021): $60K with participation from PPP
Key Investors in CardiOptics
PPP
Public-Private Partnership
What's next for CardiOptics?
The substantial expansion capital CardiOptics has raised positions it for significant growth and market penetration. As a company operating at a Series B/C stage, this latest financing is likely to fuel the expansion of its service offerings, enhancement of its technological infrastructure, and broader outreach to corporate clients. The strategic deployment of this capital will be crucial in solidifying its market position and potentially exploring new service verticals or geographical expansions. Continued investment in their proprietary ultrasound technology and specialist network will be key to maintaining a competitive edge and achieving long-term financial objectives.
See full CardiOptics company page
